Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
Portfolio Pulse from Avi Kapoor
Jim Cramer provided stock recommendations on CNBC's 'Mad Money Lightning Round.' He recommended buying Dutch Bros Inc. (NYSE:BROS) and Nutanix, Inc. (NASDAQ:NTNX), while advising caution on Abbott Laboratories (NYSE:ABT) and Canada Goose Holdings Inc. (NYSE:GOOS). He also called MeiraGTx Holdings plc (NASDAQ:MGTX) a 'worthy spec.'
May 21, 2024 | 12:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jim Cramer recommended buying Dutch Bros Inc. (NYSE:BROS) following its better-than-expected Q1 financial results and raised full-year revenue guidance.
Cramer's positive recommendation and the company's strong financial performance are likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer called MeiraGTx Holdings plc (NASDAQ:MGTX) a 'worthy spec,' noting its limited downside and potential for upside.
Cramer's recommendation as a speculative buy suggests potential for upside, which may attract risk-tolerant investors and drive the stock price up in the short term.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Jim Cramer recommended buying Nutanix, Inc. (NASDAQ:NTNX), highlighting its appeal in the enterprise software and cloud platforms market.
Cramer's positive recommendation and the company's strong market position in enterprise software and cloud platforms are likely to drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Jim Cramer advised caution on Abbott Laboratories (NYSE:ABT) due to an upcoming lawsuit in July, despite the company's strong Q1 earnings.
The upcoming lawsuit introduces uncertainty, which may offset the positive impact of the strong earnings report, leading to a neutral short-term price impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Jim Cramer recommended avoiding Canada Goose Holdings Inc. (NYSE:GOOS) despite its better-than-expected Q4 earnings, citing lack of stock movement.
Despite strong earnings, the lack of positive stock movement suggests limited investor interest, likely leading to a short-term price decline.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70